-
Product Insights
NewLikelihood of Approval Analysis for Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
Overview How likely is it that the drugs in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Overview Adrenoleukodystrophy is a disorder that...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Bimatoprost Grenod in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bimatoprost Grenod in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bimatoprost Grenod in Open-Angle Glaucoma Drug Details: Bimatoprost grenod (NCX-470) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RM-191A in Neuropathic Pain (Neuralgia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RM-191A in Neuropathic Pain (Neuralgia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RM-191A in Neuropathic Pain (Neuralgia) Drug Details: RM-191A is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EC-5026 in Inflammatory Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EC-5026 in Inflammatory Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EC-5026 in Inflammatory Pain Drug Details: EC-5026 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EC-5026 in Diabetic Neuropathic Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EC-5026 in Diabetic Neuropathic Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EC-5026 in Diabetic Neuropathic Pain Drug Details: EC-5026 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BI-685509 in Portal Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BI-685509 in Portal Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BI-685509 in Portal Hypertension Drug Details: BI-685509 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BI-685509 in Chronic Kidney Disease (Chronic Renal Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BI-685509 in Chronic Kidney Disease (Chronic Renal Failure) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BI-685509 in Chronic Kidney Disease (Chronic Renal Failure)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Fluticasone Propionate in Allergic Rhinitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fluticasone Propionate in Allergic Rhinitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fluticasone Propionate in Allergic Rhinitis Drug Details: Fluticasone propionate is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BI-685509 in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BI-685509 in Liver Cirrhosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BI-685509 in Liver Cirrhosis Drug Details: BI-685509 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BAY-3283142 in Chronic Kidney Disease (Chronic Renal Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BAY-3283142 in Chronic Kidney Disease (Chronic Renal Failure) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BAY-3283142 in Chronic Kidney Disease (Chronic Renal Failure)...